search
Back to results

Quantitative Ablation of Pulmonary Vein Vestibule in Paroxysmal Atrial Fibrillation. (AI-ablation)

Primary Purpose

Atrial Fibrillation, Arrythmia

Status
Unknown status
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
High AI in paroxysmal atrial fibrillation
Middle AI in paroxysmal atrial fibrillation
Low AI in paroxysmal atrial fibrillation
Sponsored by
Yuehui Yin
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Atrial Fibrillation focused on measuring Atrial Fibrillation, Ablation index, Quantitative Ablation

Eligibility Criteria

18 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Male and non-pregnant female subjects, 18≤age≤80.
  2. Receiving or able to tolerate anticoagulant therapy.
  3. Diagnosis of atrial fibrillation using an electrocardiogram or a dynamic electrocardiogram
  4. The longest duration of atrial fibrillation episode is less than 7 days
  5. Patient is compliant and willing to complete clinical follow-up.

Exclusion Criteria:

  1. Patients who have previously undergone catheter ablation of atrial fibrillation;
  2. Left ventricular ejection fraction <35%;
  3. Pregnancy, planned pregnancy or lactating women;
  4. Left atrial appendage thrombosis was detected by transesophageal ultrasound or intracardiac ultrasound;
  5. Abnormal blood system or liver and kidney function;
  6. Combined with severe organic heart disease (including congenital heart disease, valvular heart disease, dilated cardiomyopathy, hypertrophic cardiomyopathy, and patients with myocardial infarction or coronary artery bypass grafting);
  7. Patients who are considered unsuitable for inclusion by the investigator.

Sites / Locations

  • The Second Affilliated Hospital of Chongqing Medical UniversityRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Experimental

Experimental

Arm Label

High AI in paroxysmal atrial fibrillation

Middle AI in paroxysmal atrial fibrillation

Low AI in paroxysmal atrial fibrillation

Arm Description

In this group,patients with paroxysmal AF will receive pulmonary vein vestibule ablation with high AI value, the AI target value for the front wall and the top wall is 550, and the rear wall and the lower wall are 400.

In this group,patients with paroxysmal AF will receive pulmonary vein vestibule ablation with middle AI value, the AI target value for the front wall and the top wall is 500, and the rear wall and the lower wall are 350.

In this group,patients with paroxysmal AF will receive pulmonary vein vestibule ablation with low AI value, the AI target value for the front wall and the top wall is 450, and the rear wall and the lower wall are 300.

Outcomes

Primary Outcome Measures

Success rate of the pulmonary vein single-circle isolation.
Success rate of the pulmonary vein single-circle isolation.

Secondary Outcome Measures

Total procedure time.
Time from the start to the end of the ablation procedure
Left atrial operation time.
Left atrial operation time.
The location and number of supplemental ablation.
The number and location of the supplemental ablation required for pulmonary vein isolation after single-circle ablation
Intraoperative and postoperative stroke rates.
Intraoperative and postoperative stroke rates.
Intraoperative and postoperative pericardial tamponade rates.
Intraoperative and postoperative pericardial tamponade rates.
Number of steam pop during ablation.
Number of steam pop during ablation.
the proportion of sinus rhythm within 1 year
Proportion of patients who successfully maintained sinus rhythm within 1 year after ablation.
Recurrence rate of atrial fibrillation
Diagnostic criteria for recurrence of atrial fibrillation: a blank period of 3 months after surgery. After 3 months of ablation surgery, atrial fibrillation/atrial flutter/atrial tachycardia with a duration of more than 30 seconds on the ECG was considered to be a recurrence of atrial fibrillation.

Full Information

First Posted
June 7, 2019
Last Updated
September 14, 2020
Sponsor
Yuehui Yin
search

1. Study Identification

Unique Protocol Identification Number
NCT04549714
Brief Title
Quantitative Ablation of Pulmonary Vein Vestibule in Paroxysmal Atrial Fibrillation.
Acronym
AI-ablation
Official Title
A Prospective,Single Center, Randomized Controlled Trial of Quantitative Ablation of Pulmonary Vein Vestibule in Patients With Paroxysmal Atrial Fibrillation..
Study Type
Interventional

2. Study Status

Record Verification Date
September 2020
Overall Recruitment Status
Unknown status
Study Start Date
June 7, 2019 (Actual)
Primary Completion Date
December 31, 2020 (Anticipated)
Study Completion Date
August 31, 2021 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Yuehui Yin

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this trial is to explore the optimal AI value for isolating the pulmonary veins and achieving left ventricular apex and mitral isthmus block. Patients with atrial fibrillation who are scheduled to undergo catheter ablation will be randomized to different groups, then every group receive circumferential pulmonary vein isolation with different AI values. The relevant indicators such as the proportion of pulmonary vein single-circle isolation, operation time, the incidence of complications, and the proportion of recurrence of atrial fibrillation and other atrial arrhythmias after 1 year were collected.
Detailed Description
This is a prospective, single-center, randomized controlled trial. In this part,a total of 90 patients with paroxysmal atrial fibrillation who are scheduled for catheter ablation were randomly divided into 3 groups, 30 patients in each group. For the first group, the AI target value for the front wall and the top wall is 550, and the rear wall and the lower wall are 400. For the second group, the AI target values for the front wall and the top wall are 500, the rear wall and the lower wall are 350. For the third group, the AI target values for the front wall and top wall are 450, the rear wall and the lower wall are 300. The pressure value at each point is 5-15 g, and the distance between adjacent ablation points is less than 5 mm. The relevant indicators such as single-circle isolation rate of the pulmonary vein, operation time, the left atrial operation time, and the supplemental ablation site are recoded. The incidence of intraoperative and postoperative complications such as stroke, pericardial tamponade and steam pop during ablation are observed. Dynamic electrocardiography is performed during the follow-up period to evaluate the proportion of sinus rhythm within 1 year.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Atrial Fibrillation, Arrythmia
Keywords
Atrial Fibrillation, Ablation index, Quantitative Ablation

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderOutcomes Assessor
Masking Description
Patients enrolled in the study were randomly assigned to different surgical groups using random envelopes. All study personnel were blind to treatment allocation and had no way of influencing whether a participant would receive high or low AI ablation.
Allocation
Randomized
Enrollment
90 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
High AI in paroxysmal atrial fibrillation
Arm Type
Experimental
Arm Description
In this group,patients with paroxysmal AF will receive pulmonary vein vestibule ablation with high AI value, the AI target value for the front wall and the top wall is 550, and the rear wall and the lower wall are 400.
Arm Title
Middle AI in paroxysmal atrial fibrillation
Arm Type
Experimental
Arm Description
In this group,patients with paroxysmal AF will receive pulmonary vein vestibule ablation with middle AI value, the AI target value for the front wall and the top wall is 500, and the rear wall and the lower wall are 350.
Arm Title
Low AI in paroxysmal atrial fibrillation
Arm Type
Experimental
Arm Description
In this group,patients with paroxysmal AF will receive pulmonary vein vestibule ablation with low AI value, the AI target value for the front wall and the top wall is 450, and the rear wall and the lower wall are 300.
Intervention Type
Procedure
Intervention Name(s)
High AI in paroxysmal atrial fibrillation
Intervention Description
Patients with paroxysmal AF will receive pulmonary vein vestibule ablation with high AI value, the AI target value for the front wall and the top wall is 550, and the rear wall and the lower wall are 400.
Intervention Type
Procedure
Intervention Name(s)
Middle AI in paroxysmal atrial fibrillation
Intervention Description
Patients with paroxysmal AF will receive pulmonary vein vestibule ablation with middle AI value, the AI target value for the front wall and the top wall is 500, and the rear wall and the lower wall are 350.
Intervention Type
Procedure
Intervention Name(s)
Low AI in paroxysmal atrial fibrillation
Intervention Description
Patients with paroxysmal AF will receive pulmonary vein vestibule ablation with low AI value, the AI target value for the front wall and the top wall is 450, and the rear wall and the lower wall are 300.
Primary Outcome Measure Information:
Title
Success rate of the pulmonary vein single-circle isolation.
Description
Success rate of the pulmonary vein single-circle isolation.
Time Frame
Immediately after ablation
Secondary Outcome Measure Information:
Title
Total procedure time.
Description
Time from the start to the end of the ablation procedure
Time Frame
Immediately after ablation
Title
Left atrial operation time.
Description
Left atrial operation time.
Time Frame
Immediately after ablation
Title
The location and number of supplemental ablation.
Description
The number and location of the supplemental ablation required for pulmonary vein isolation after single-circle ablation
Time Frame
Immediately after ablation
Title
Intraoperative and postoperative stroke rates.
Description
Intraoperative and postoperative stroke rates.
Time Frame
From the start of procedure to 7 days after ablation
Title
Intraoperative and postoperative pericardial tamponade rates.
Description
Intraoperative and postoperative pericardial tamponade rates.
Time Frame
From the start of procedure to 7 days after ablation
Title
Number of steam pop during ablation.
Description
Number of steam pop during ablation.
Time Frame
Immediately after ablation
Title
the proportion of sinus rhythm within 1 year
Description
Proportion of patients who successfully maintained sinus rhythm within 1 year after ablation.
Time Frame
1 year
Title
Recurrence rate of atrial fibrillation
Description
Diagnostic criteria for recurrence of atrial fibrillation: a blank period of 3 months after surgery. After 3 months of ablation surgery, atrial fibrillation/atrial flutter/atrial tachycardia with a duration of more than 30 seconds on the ECG was considered to be a recurrence of atrial fibrillation.
Time Frame
1 year

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Male and non-pregnant female subjects, 18≤age≤80. Receiving or able to tolerate anticoagulant therapy. Diagnosis of atrial fibrillation using an electrocardiogram or a dynamic electrocardiogram The longest duration of atrial fibrillation episode is less than 7 days Patient is compliant and willing to complete clinical follow-up. Exclusion Criteria: Patients who have previously undergone catheter ablation of atrial fibrillation; Left ventricular ejection fraction <35%; Pregnancy, planned pregnancy or lactating women; Left atrial appendage thrombosis was detected by transesophageal ultrasound or intracardiac ultrasound; Abnormal blood system or liver and kidney function; Combined with severe organic heart disease (including congenital heart disease, valvular heart disease, dilated cardiomyopathy, hypertrophic cardiomyopathy, and patients with myocardial infarction or coronary artery bypass grafting); Patients who are considered unsuitable for inclusion by the investigator.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
zhiyu Ling, MD
Phone
0086-13512362075
Email
lingzy@163.com
Facility Information:
Facility Name
The Second Affilliated Hospital of Chongqing Medical University
City
Chongqing
State/Province
Chongqing
ZIP/Postal Code
400010
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
ZHIYU LING, MD
Phone
+8613512362075
Email
lingzy1977@163.com
First Name & Middle Initial & Last Name & Degree
YANPING XU, MD
Phone
+8613618273302
Email
yxu2013@163.com
First Name & Middle Initial & Last Name & Degree
Qingsong Xiong

12. IPD Sharing Statement

Citations:
PubMed Identifier
28639728
Citation
Hussein A, Das M, Chaturvedi V, Asfour IK, Daryanani N, Morgan M, Ronayne C, Shaw M, Snowdon R, Gupta D. Prospective use of Ablation Index targets improves clinical outcomes following ablation for atrial fibrillation. J Cardiovasc Electrophysiol. 2017 Sep;28(9):1037-1047. doi: 10.1111/jce.13281. Epub 2017 Jul 26.
Results Reference
background
Citation
Nakagawa H, Ikeda A, Govari A, et al.Prospective study using a new formula incorporating contact force, radiofrequency power and application time (Force-Power-Time Index) for quantifying lesion formation to guide long continuous atrial lesions in the beating canine heart. Circulation2013; 128:A12104.
Results Reference
background
PubMed Identifier
29600792
Citation
Taghji P, El Haddad M, Phlips T, Wolf M, Knecht S, Vandekerckhove Y, Tavernier R, Nakagawa H, Duytschaever M. Evaluation of a Strategy Aiming to Enclose the Pulmonary Veins With Contiguous and Optimized Radiofrequency Lesions in Paroxysmal Atrial Fibrillation: A Pilot Study. JACC Clin Electrophysiol. 2018 Jan;4(1):99-108. doi: 10.1016/j.jacep.2017.06.023. Epub 2017 Sep 27.
Results Reference
background
PubMed Identifier
21615817
Citation
Beinart R, Abbara S, Blum A, Ferencik M, Heist K, Ruskin J, Mansour M. Left atrial wall thickness variability measured by CT scans in patients undergoing pulmonary vein isolation. J Cardiovasc Electrophysiol. 2011 Nov;22(11):1232-6. doi: 10.1111/j.1540-8167.2011.02100.x. Epub 2011 May 26.
Results Reference
background

Learn more about this trial

Quantitative Ablation of Pulmonary Vein Vestibule in Paroxysmal Atrial Fibrillation.

We'll reach out to this number within 24 hrs